Table 1:

Demographics and outcomes for REDvent patients and matched historical controls. Median (IQR) and P value from Mann-Whitney-U test for continuous data. n (%) and P value reported from Chi-squared test for categorical data.

Variable	REDvent (N = 32)	Control (N = 128)	P
Age (mo)	100.7 (33.7,150.4)	70.3 (13.3,158)	0.45
Weight (kg)	34 (9.9,50)	17.3 (9.3,41)	0.2
Male	19 (59.4%)	67 (52.3%)	0.6
Initial OI	21.6 (12.7,29.7)	18.1 (10.7,27.7)	0.54
Immunosuppressed	13 (40.6%)	48 (37.5%)	0.9
Mortality	7 (21.9%)	37 (28.9%)	0.56
28 D VFDs (days)	20.17 (9.21, 22.54)	14.33 (0.00, 20.67)	0.03
Days to first SBT – Survivors (days)	4.42 (2.92, 7.08)	6.42 (3.42, 11.33)	< 0.01 *
LMV - Survivors (days)	6.33 (4.33, 9.17)	9.83 (5.50,15.42)	< 0.01 *
Re-intubation	0 (0%)	10 (7.8%)	0.10

^*Significance was assessed with Kaplan-Meier survivor analysis.